To The Moon

Spero Therapeutics(SPRO) stock is getting a boost from U.S. Food and Drug Administration (FDA) news. That includes positive feedback for its complicated urinary tract infection (cUTI) treatment. The company is now planning an additional Phase 3 clinical trial of tebipenem HBr. Source: ShutterstockSpero Therapeutics(NASDAQ:SPRO) stock is climbing higher on Wednesdaythanks to positive feedbackfrom the U.S. Food and Drug Administration (FDA).The news concerns plans for the company to resubmit tebipenem HBr for the treatment of complicated urinary tract infection (cUTI). During a Type A meeting, the FDA said “positive results from an additional Phase 3 trial […] could be sufficient to support the approval of tebipenem HBr for cUTI.”It’s worth noting that Spero has already conducted a Phase 3 c

$Sidus Space Inc.(SIDU)$CAPE CANAVERAL, Fla. --(BUSINESS WIRE)-- Sidus Space, Inc . (NASDAQ:SIDU), a Space-as-a-Service satellite company focused on mission critical hardware manufacturing; multi-disciplinary engineering services; satellite design, production, launch planning, mission operations; and in-orbit support, is pleased to announce its growing relationship with Teledyne Marine, a part of Teledyne Technologies, Inc. (NYSE:TDY), following a noteworthy Q2 2022. The three-month period marks the strongest revenue quarter between the parties since their partnership began four years ago.

Micron Technology (MU)Following the passage of the CHIPS Act,Micron Technology(NASDAQ:MU) said it willinvest $40 billionin memory chip manufacturing through 2030, creating up to 40,000 jobs in the United States. The resultant additional capacity will take Micron’s U.S. market share from 2% to 10%, the company said.Micron’s plans could includebuilding a mega fabrication plantin the United States. Rob Beard, the company’s senior vice president and general counsel, said Micron has been eyeing a mega fab “for a long time.”MU stock topped out in January and is down around 34% from its high. The company recently reported disappointing quarterly results andslashed its outlook. However, since hitting a 52-week low in early July, MU is up 26%.Citi analysts saythe stock has bottomed. If that’s the c

$Amazon.com(AMZN)$AMZN is rapidlyentering the healthcare sector, which was worth $808 billion in the U.S. alone last year, according to one estimate. I believe that, by 2030, Amazon could get 5%-10% of the total healthcare market by getting into the telehealth and prescription markets.Add in some overseas healthcare revenue, and we’re talking about a business that could easily generate $100 billion of annual revenue for AMZN within five years, moving the needle a great deal for the company and its shares.As I’ve noted in previous columns, I believe that Amazon’s new CEO, Andy Jassy, is much “hungrier” for success than his predecessor Jeff Bezos. Consequently, AMZN’s forays into businesses other than the cloud and e-commerce are far more likely to bea

$Amazon.com(AMZN)$AMZN is rapidlyentering the healthcare sector, which was worth $808 billion in the U.S. alone last year, according to one estimate. I believe that, by 2030, Amazon could get 5%-10% of the total healthcare market by getting into the telehealth and prescription markets.Add in some overseas healthcare revenue, and we’re talking about a business that could easily generate $100 billion of annual revenue for AMZN within five years, moving the needle a great deal for the company and its shares.As I’ve noted in previous columns, I believe that Amazon’s new CEO, Andy Jassy, is much “hungrier” for success than his predecessor Jeff Bezos. Consequently, AMZN’s forays into businesses other than the cloud and e-commerce are far more likely to bea

$GameStop(GME)$I would not be too surprised if  Cohen eventually executes a similar head fake with GME stock. He could easily find a way to drive the shares up and then suddenly sell his entire stake, causing all of GameStop’s “meme premium,” if you will, to be erased.GME stock is trading at1.7 times its trailing sales, well above the valuations of other, much more profitable retailers, such asNordstrom(NYSE:JWN), whosetrailing P/S ratiois 0.24 andBest Buy(NYSE:BBY), which has a trailing P/S ratio of 0.37.

$Grab Holdings(GRAB)$ Grab Holdings (NASDAQ:GRAB) is a Singapore-based company that provides ride-hailing and food delivery in a number of Southeast Asian companies. The stock took a hit last week after news emerged that two more executives at the company’s fintech quit. But that’s not all, as Reuters reported that other senior executives have left in recent months too.In other words, the company’s earnings losses are widening. And if a global recession occurs, this will hurt the stock. So, like Abercrombie & Fitch, this one is also among the stocks to avoid.

$Snowflake(SNOW)$ SNOW is a unique stock in the sense Warren Buffettmade a beton its during its highly successful initial public offering, or IPO. Buffett is famously weary of IPOs. The company still counts him as a shareholder and asInvestorPlacecontributor Joel Baglole reports, itscustomer base is growingat a “brisk pace.”

$Sea Ltd(SE)$Primarily, global economic woes impose substantial concerns over SE stock. PerBloomberg, “Shoppers emerging from pandemic lockdowns are cutting back on online purchases, shifting toward essentials during a potential recession.”While the inflationary trend of the U.S. dollar obviously garners the most attention, Sea’s home nation hasn’t been immune. Indeed, anotherBloombergreport last month noted that Singapore’sinflation rate increased 4.4% in Junefrom a year ago. Therefore, the news agency stated that this dynamic bolsters the case for more tightening.

$Sundial Growers Inc.(SNDL)$This company is still very good in my mind, I will look for an opportunity to buy it.